{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:49:32Z","timestamp":1782859772256,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nrleng.2019.02.011","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:49:19Z","timestamp":1617738559000},"page":"757-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Focal status epilepticus: a review of pharmacological treatment"],"prefix":"10.1016","volume":"37","author":[{"given":"N.","family":"Huertas Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barros Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Hernando Requejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"D\u00edaz D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2019.02.011_bib0005","first-page":"122","article-title":"Advancements in the critical care management of status epilepticus","volume":"23","author":"Bauerschmidt","year":"2017","journal-title":"Curr Opin in Crit Care."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcrc.2016.03.003","article-title":"Characteristics and outcome of patients with the ICU admission diagnosis of status epilepticus in Australia and New Zealand","volume":"34","author":"Hay","year":"2016","journal-title":"J Crit Care."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/jcm5080071","article-title":"Status epilepticus: epidemiology and public health needs","volume":"5","author":"S\u00e1nchez","year":"2016","journal-title":"J Clin Med."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0020","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.58.7.1070","article-title":"Incidence and mortality of generalized convulsive status epilepticus in California","volume":"58","author":"Wu","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0025","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2013 Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commisision for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","article-title":"25 years of advances in the definition, classification and treatment of status epilepticus","volume":"44","author":"Trinka","year":"2017","journal-title":"Seizure."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.seizure.2017.02.015","article-title":"Challenges in the treatment of convulsive status epilepticus","volume":"47","author":"Zaccara","year":"2017","journal-title":"Seizure."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0045","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.nrl.2013.12.020","article-title":"Gu\u00eda oficial de la Sociedad Espa\u00f1ola de Neurolog\u00eda de pr\u00e1ctica cl\u00ednica en epilepsia","volume":"31","author":"Mercad\u00e9 Cerd\u00e1","year":"2016","journal-title":"Neurolog\u00eda."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med."},{"issue":"Pt A","key":"10.1016\/j.nrleng.2019.02.011_bib0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2016.09.020","article-title":"Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials","volume":"64","author":"Brigo","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0070","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2011.03056.x","article-title":"Second-line status epilepticus treatment: comparison of phenytoin, valproate and levetiracetam","volume":"52","author":"Alvarez","year":"2011","journal-title":"Epilepsia."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eplepsyres.2015.04.013","article-title":"Management of generalised convulsive status epilepticus (SE): a prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam \u2013 Pilot study","volume":"114","author":"Mundlamuri","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jocn.2014.12.013","article-title":"Levetiracetam versus phenytoin in management of status epilepticus","volume":"22","author":"Chakravarthi","year":"2015","journal-title":"J Clin Neurosci."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Yasiry","year":"2014","journal-title":"Seizure."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2015.04.003","article-title":"Intravenous levetiracetam treatment in status epilepticus: a prospective study","volume":"114","author":"Atmaca","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.eplepsyres.2013.08.001","article-title":"Treatment and course of different subtypes of status epilepticus","volume":"107","author":"Rantsch","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0100","first-page":"CD003723","article-title":"Anticonvulsant therapy for status epilepticus","author":"Prasad","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/epi.12058","article-title":"Lacosamide as a new treatment option in status epilepticus","volume":"54","author":"H\u00f6fler","year":"2013","journal-title":"Epilepsia."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/WNF.0b013e31829b21ba","article-title":"Single-dose oral lacosamide in refractory simple partial status epilepticus","volume":"36","author":"Hawkes","year":"2013","journal-title":"Clin Neuropharmacol."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1684\/epd.2013.0565","article-title":"Efficacy of lacosamide on seizures and myoclonus in a patient withepilepsia partialis continua","volume":"15","author":"Spalletti","year":"2013","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12028-016-0322-2","article-title":"The safety and effectiveness of intravenous lacosamide for refractory status epilepticus in the critically III","volume":"26","author":"Newey","year":"2017","journal-title":"Neurocrit Care."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yebeh.2018.04.025","article-title":"Intravenous lacosamide (LCM) in status epilepticus (SE): weight-adjusted dose and efficacy","volume":"84","author":"Santamarina","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.yebeh.2015.01.036","article-title":"Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus","volume":"45","author":"Redecker","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4103\/ijccm.IJCCM_327_17","article-title":"A comparative study of midazolam and target-controlled propofol infusi\u00f3n in the treatment of refractory status epilepticus","volume":"22","author":"Masapu","year":"2018","journal-title":"Indian J Crit Care Med."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0140","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/CCM.0000000000000881","article-title":"Status epilepticus: impact of therapeutic coma on outcome","volume":"43","author":"Marchi","year":"2015","journal-title":"Crit Care Med."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nrl.2015.11.018","article-title":"Estudio observacional multic\u00e9ntrico retrospectivo sobre el manejo cl\u00ednico y terap\u00e9utico de los diferentes tipos de estatus epil\u00e9ptico en la pr\u00e1ctica cl\u00ednica","volume":"32","author":"De la Morena Vicente","year":"2017","journal-title":"Neurolog\u00eda."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.seizure.2014.11.005","article-title":"The management of Convulsive Refractory Status Epilepticus in adults in the UK: no consistency in practice and little access to continuous EEG monitoring","volume":"24","author":"Patel","year":"2015","journal-title":"Seizure."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40265-017-0859-1","article-title":"Pharmacotherapy for refractory and super-refractory status epilepticus in adults","volume":"78","author":"Holtkamp","year":"2018","journal-title":"Drugs."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s13311-018-0640-5","article-title":"Treatment of refractory and super-refractory status epilepticus","volume":"15","author":"Rai","year":"2018","journal-title":"Neurotherapeutics."},{"issue":"Suppl 8","key":"10.1016\/j.nrleng.2019.02.011_bib0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1167.2011.03237.x","article-title":"Established status epilepticus treatment trial (ESETT)","volume":"52","author":"Cock","year":"2011","journal-title":"Epilepsia."},{"issue":"Suppl 6","key":"10.1016\/j.nrleng.2019.02.011_bib0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/epi.12288","article-title":"The established status epilepticus trial 2013","volume":"54","author":"Bleck","year":"2013","journal-title":"Epilepsia."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0180","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.3892\/etm.2017.4979","article-title":"Aphasic status epilepticus as the sole symptom of epilepsy: a case report and literature review","volume":"14","author":"Qiu","year":"2017","journal-title":"Exp Ther Med."},{"key":"10.1016\/j.nrleng.2019.02.011_bib0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.seizure.2016.10.010","article-title":"Epilepsia partialis continua: a review","volume":"44","author":"Mameniskien\u00e9","year":"2017","journal-title":"Seizure."}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580821000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580821000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:35:13Z","timestamp":1761881713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580821000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2173580821000432"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2019.02.011","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focal status epilepticus: a review of pharmacological treatment","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2019.02.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}